TY - JOUR
T1 - Telomere length in the gastric mucosa after Helicobacter pylori eradication and its potential role in the gastric carcinogenesis
AU - Tahara, Tomomitsu
AU - Tahara, Sayumi
AU - Tuskamoto, Tetsuya
AU - Horiguchi, Noriyuki
AU - Kawamura, Tomohiko
AU - Okubo, Masaaki
AU - Ishizuka, Takamitsu
AU - Nagasaka, Mitsuo
AU - Nakagawa, Yoshihito
AU - Shibata, Tomoyuki
AU - Kuroda, Makoto
AU - Ohmiya, Naoki
N1 - Publisher Copyright:
© 2017, Springer International Publishing Switzerland.
PY - 2018/2/1
Y1 - 2018/2/1
N2 - The molecular mechanisms of gastric carcinogenesis after Helicobacter pylori (H. pylori) eradication remain unclear. We examined the telomere length of gastric mucosa samples after successful H. pylori eradication in patients without and those with gastric cancer. Telomere length was measured by the real-time PCR among four different groups of biopsies: gastric body from subjects without history of H. pylori infection (Hp-: n = 23), gastric body from cancer-free subjects after H. pylori eradication (cancer-free body: n = 24), gastric body from early gastric cancer patients diagnosed after H. pylori eradication (EGC body: n = 35) and its paired samples from adjacent mucosa of cancerous area (EGC ADJ: n = 35). The Hp-group presented the longest telomeres among the all groups (Hp- vs. all others, all P < 0.05). Samples from EGC body group showed shorter telomere length than the samples from cancer-free body groups (P < 0.05). Conversely, samples from EGC ADJ group showed rather longer telomere length compared to the EGC body group (P < 0.05), which was also confirmed by the comparison of 35 matched samples (P = 0.0007). Among the samples after H. pylori eradication, shorter telomere length was associated with higher expression of IL-1B and NF-kB (P < 0.0001, 0.0006, respectively). Longer telomere length was also associated with higher expression of TNF-A (P = 0.01). Telomere shortening seems to be important initial steps in gastric cancer predisposition after H. pylori eradication, while it might shift to lengthening to acquire more aggressive pathway to develop cancer.
AB - The molecular mechanisms of gastric carcinogenesis after Helicobacter pylori (H. pylori) eradication remain unclear. We examined the telomere length of gastric mucosa samples after successful H. pylori eradication in patients without and those with gastric cancer. Telomere length was measured by the real-time PCR among four different groups of biopsies: gastric body from subjects without history of H. pylori infection (Hp-: n = 23), gastric body from cancer-free subjects after H. pylori eradication (cancer-free body: n = 24), gastric body from early gastric cancer patients diagnosed after H. pylori eradication (EGC body: n = 35) and its paired samples from adjacent mucosa of cancerous area (EGC ADJ: n = 35). The Hp-group presented the longest telomeres among the all groups (Hp- vs. all others, all P < 0.05). Samples from EGC body group showed shorter telomere length than the samples from cancer-free body groups (P < 0.05). Conversely, samples from EGC ADJ group showed rather longer telomere length compared to the EGC body group (P < 0.05), which was also confirmed by the comparison of 35 matched samples (P = 0.0007). Among the samples after H. pylori eradication, shorter telomere length was associated with higher expression of IL-1B and NF-kB (P < 0.0001, 0.0006, respectively). Longer telomere length was also associated with higher expression of TNF-A (P = 0.01). Telomere shortening seems to be important initial steps in gastric cancer predisposition after H. pylori eradication, while it might shift to lengthening to acquire more aggressive pathway to develop cancer.
KW - Gastric mucosa
KW - H. pylori eradication
KW - Telomere length
UR - http://www.scopus.com/inward/record.url?scp=85012906072&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85012906072&partnerID=8YFLogxK
U2 - 10.1007/s10238-017-0458-1
DO - 10.1007/s10238-017-0458-1
M3 - Article
C2 - 28197807
AN - SCOPUS:85012906072
SN - 1591-8890
VL - 18
SP - 21
EP - 26
JO - Clinical and Experimental Medicine
JF - Clinical and Experimental Medicine
IS - 1
ER -